Inspire Medical Systems, Inc.

NYSE INSP

Inspire Medical Systems, Inc. Price to Earnings Ratio (P/E) on January 14, 2025: 154.14

Inspire Medical Systems, Inc. Price to Earnings Ratio (P/E) is 154.14 on January 14, 2025, a 158.99% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Inspire Medical Systems, Inc. 52-week high Price to Earnings Ratio (P/E) is 1,074.87 on September 23, 2024, which is 597.32% above the current Price to Earnings Ratio (P/E).
  • Inspire Medical Systems, Inc. 52-week low Price to Earnings Ratio (P/E) is -474.16 on May 02, 2024, which is -407.61% below the current Price to Earnings Ratio (P/E).
  • Inspire Medical Systems, Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is 119.16.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
NYSE: INSP

Inspire Medical Systems, Inc.

CEO Mr. Timothy P. Herbert
IPO Date May 3, 2018
Location United States
Headquarters 5500 Wayzata Boulevard
Employees 1,011
Sector Health Care
Industries
Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Similar companies

OM

Outset Medical, Inc.

USD 0.81

0.53%

PODD

Insulet Corporation

USD 267.04

-0.35%

TMDX

TransMedics Group, Inc.

USD 62.54

-2.36%

GMED

Globus Medical, Inc.

USD 88.18

1.15%

INMD

InMode Ltd.

USD 16.07

0.63%

DXCM

DexCom, Inc.

USD 79.17

-0.84%

TNDM

Tandem Diabetes Care, Inc.

USD 35.79

-1.16%

NARI

Inari Medical, Inc.

USD 79.30

-0.05%

PEN

Penumbra, Inc.

USD 252.89

2.41%

NVCR

NovoCure Limited

USD 26.23

-4.20%

CLPT

ClearPoint Neuro, Inc.

USD 14.70

-4.54%

GKOS

Glaukos Corporation

USD 147.95

-2.58%

StockViz Staff

January 15, 2025

Any question? Send us an email